Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 584585
                    [Title] => AstraZeneca's anti-cholesterol drug shows benefits in cardiovascular disease management
                    [Summary] => 
Two recent studies have shown that the AstraZeneca anti-cholesterol drug rosuvastatin demonstrated ability to reduce the risk of cardiovascular disease and is better than simvastatin and atorvastatin in the overall management of hypercholesterolemia.
                    [DatePublished] => 2010-06-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 569660
                    [Title] => 8 new risk factors for heart disease
                    [Summary] => 
For those who are concerned about getting heart disease, please take note. The US Preventive Services Task Force recently added new risk factors to the development of heart disease.
                    [DatePublished] => 2010-04-27 00:00:00
                    [ColumnID] => 134789
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 530592
                    [Title] => Anti-cholesterol drug reduces threat of heart complications
                    [Summary] => 
Patients with progressive hardening and narrowing of the arteries called atherosclerosis, are in constant fear of heart attacks, strokes and other cardiovascular (CV) complications hanging over their heads like the sword of Damocles.
                    [DatePublished] => 2009-12-10 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1219714
                    [AuthorName] => Cess Lim Abrahan
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 63152
                    [Title] => Can rosuvastatin save the world?
                    [Summary] => 
Ever since I was young, I have always loved astronomy. I would memorize all the nine planets, the names of their moons, their distance from the earth, and other peculiar details. My vocabulary was filled with words like meteor, asteroid, comet, and universe.
                    [DatePublished] => 2008-05-20 00:00:00
                    [ColumnID] => 134789
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 196998
                    [Title] => New anti-cholesterol drug in the market
                    [Summary] => Management of coronary heart disease (CHD), a major cause of death in the Western world and commonly associated with atherosclerosis, recently got a new boost with the approval by Canadian authorities of Rosuvastatin for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia, conditions better known as "high cholesterol."


Canadian medical experts agree that low density lipoprotein (LDL-C), commonly known as the "bad" cholesterol, is the most significant contributory risk factor for atherosclerosis.


                    [DatePublished] => 2003-02-27 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

ROSUVASTATIN

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 584585
                    [Title] => AstraZeneca's anti-cholesterol drug shows benefits in cardiovascular disease management
                    [Summary] => 
Two recent studies have shown that the AstraZeneca anti-cholesterol drug rosuvastatin demonstrated ability to reduce the risk of cardiovascular disease and is better than simvastatin and atorvastatin in the overall management of hypercholesterolemia.
                    [DatePublished] => 2010-06-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 569660
                    [Title] => 8 new risk factors for heart disease
                    [Summary] => 
For those who are concerned about getting heart disease, please take note. The US Preventive Services Task Force recently added new risk factors to the development of heart disease.
                    [DatePublished] => 2010-04-27 00:00:00
                    [ColumnID] => 134789
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 530592
                    [Title] => Anti-cholesterol drug reduces threat of heart complications
                    [Summary] => 
Patients with progressive hardening and narrowing of the arteries called atherosclerosis, are in constant fear of heart attacks, strokes and other cardiovascular (CV) complications hanging over their heads like the sword of Damocles.
                    [DatePublished] => 2009-12-10 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1219714
                    [AuthorName] => Cess Lim Abrahan
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 63152
                    [Title] => Can rosuvastatin save the world?
                    [Summary] => 
Ever since I was young, I have always loved astronomy. I would memorize all the nine planets, the names of their moons, their distance from the earth, and other peculiar details. My vocabulary was filled with words like meteor, asteroid, comet, and universe.
                    [DatePublished] => 2008-05-20 00:00:00
                    [ColumnID] => 134789
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 196998
                    [Title] => New anti-cholesterol drug in the market
                    [Summary] => Management of coronary heart disease (CHD), a major cause of death in the Western world and commonly associated with atherosclerosis, recently got a new boost with the approval by Canadian authorities of Rosuvastatin for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia, conditions better known as "high cholesterol."


Canadian medical experts agree that low density lipoprotein (LDL-C), commonly known as the "bad" cholesterol, is the most significant contributory risk factor for atherosclerosis.


                    [DatePublished] => 2003-02-27 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

AstraZeneca's anti-cholesterol drug shows benefits in cardiovascular disease management

June 17, 2010 - 12:00am

Two recent studies have shown that the AstraZeneca anti-cholesterol drug rosuvastatin demonstrated ability to reduce the risk of cardiovascular disease and is better than simvastatin and atorvastatin in the overall...

Science and Environment

8 new risk factors for heart disease

By Dr. Willie T. Ong | April 27, 2010 - 12:00am

For those who are concerned about getting heart disease, please take note. The US Preventive Services Task Force recently added new risk factors to the development of heart disease.

Health And Family

Anti-cholesterol drug reduces threat of heart complications

By Cess Lim Abrahan | December 10, 2009 - 12:00am

Patients with progressive hardening and narrowing of the arteries called atherosclerosis, are in constant fear of heart attacks, strokes and other cardiovascular (CV) complications hanging over their heads like the...

Science and Environment

Can rosuvastatin save the world?

By Dr. Willie T. Ong | May 20, 2008 - 12:00am

Ever since I was young, I have always loved astronomy. I would memorize all the nine planets, the names of their moons, their distance from the earth, and other peculiar details. My vocabulary was filled with words...

Health And Family

New anti-cholesterol drug in the market

February 27, 2003 - 12:00am

Management of coronary heart disease (CHD), a major cause of death in the Western world and commonly associated with atherosclerosis, recently got a new boost with the approval by Canadian authorities of Rosuvastatin...

Science and Environment